Methotrexate (Mtx) is widely used in various cancer and inflammatory diseases. Hepatotoxicity is the most serious side effect in long-term Mtx treatment. Therefore, the present study aimed to investigate the protective effect of L-Carnitine against Mtx-induced injury in rat's hepatocytes. Fifty male albino rats, each weighing 120-130g were used. The experimental animals were equally divided into five groups , 10 rats each, and treated intraperitoneally (twice /week) as follows : (1) In Methotrexate-treated group, the ultrastructural study on hepatocytes revealed pyknotic nuclei with abnormally electron-dense chromatin, irregular nuclear envelopes, electron-dense mitochondria and fragmented rough endoplasmic reticulum.In addition to dilatation and congestion of the hepatic sinusoids as well as increase in lipid droplets and collagen fibers. Rats co-treated with L-Carnitine against Mtx showed significant improvement in the ultrastructure abnormalities of hepatocytes caused by Mtx. On the other hand, mild to moderate improvement in hepatocytes were observed in the group treated with Mtx followed by L-Carnitine. These results indicated that co-and post L-Carnitine treatment can diminish Mtx-induced liver ultrastructural injuries. The beneficial effect was more pronounced in L-Carnitine co treated with Methotrexate.
Introduction
Methotrexate (Mtx), a folic acid antagonist, is a chemotherapeutic agent widely used in the treatment of some types of cancers and various inflammatory diseases such as psoriasis and rheumatoid arthritis. However, the efficacy of this agent in high doses has been associated with hepatotoxicity ( Mtx is metabolized and stored in hepatocytes in the polyglutamated form (Chladek et al., 1997) .The presence of higher levels of polyglutamates causes a longer intracellular presence of the drug, and this has been suggested as a mechanism for hepatotoxicity (Kremer et al., 1986).
The mechanisms of Mtx toxicity are not yet fully understood, but recent studies have shown that a decrease in the levels of cellular glutathione (GSH) .It was demonstrated that cytosolic nicotinamide adenosine diphosphate (NADP)-dependent dehydrogenases are inhibited by Mtx, suggesting that the drug decreases the availability of NADPH in cells. Under normal conditions, NADPH is used by glutathione reductase to maintain the reduced state of GSH, an important cytosolic antioxidant that protects cells against reactive oxygen species (ROS). Thus, the significant reduction in GSH levels induced by Mtx therapy leads to reduction in the level of the antioxidant enzyme defence system, sensitizing the cells to ROS. Considering the relationship between GSH and the deleterious effects of Mtx, interest has focused on antioxidant compounds that can either stimulate GSH synthesis or act as direct antioxidants (Soliman, 2009) .
L-Carnitine (LC) is a small water-soluble molecule which plays an important role in fat metabolism. It is essential for the normal mitochondrial oxidation of fatty acids and excretion of acyl-coenzyme A (acyl-CoA) esters and affects adenosine triphosphate levels The aim of the present study was to evaluate whether co-or post-L-Carnitine treatment has any beneficial effect on MTX-induced hepatotoxicity in rats.
Materials and Methods

Experimental animals :
Fifty male albino rats (Rattus norvegicus) their weight ranging from 120-130 g, were obtained from the animal house of Faculty of Medicine, Ain Shams University. The animals were placed in cages, fed on laboratory rodent chow and tap water.
1.2
The Drugs :-1) Methotrexate (Mtx, 4-amino-N10-methyl folic acid), a folic acid dihydrofolate reductase inhibitor, affects primarily the tissues that are growing most rapidly. Methotrexate was obtained from Sigma Pharmaceutical Industries, Egypt as injections.
2) L-Carnitine (β-hydroxy-γ-N-trimethylaminobutyric acid) is a cofactor required for transport of long-chain fatty acids into the mitochondrial matrix, where they underdo β-oxidation for cellular energy production. L-Carnitine is found in animal food sources. L-Carnitine is obtained from the Egyptian Pharmacists Company as injection. ( Tousson et al. 2014 ) 
Experimental animal grouping:
The animals were divided into 5 groups, 10 rats each:(1) The rats did not receive any treatment (control group ); (2) The rats given 300mg L-Carnitine /100g b.w. for 4 weeks ; (3) rats given 0.045mg Methotrexate /100g b.w. for 4 weeks ; (4) The rats given 0.045mg Methotrexate /100g b.w. with 300mg L-Carnitine /100g b.w. for 4 weeks ; (5) The rats given 0.045mg Methotrexate /100g b.w. for 4 weeks then given 300mg L-Carnitine /100g b.w. for other 4 weeks . Rats of all groups were injected intraperitoneally twice per week.
Transmission electron microscopy study.
For electron microscopical investigation, freshly-excised pieces of the liver tissue were dissected to about 1mm³ in size and fixed in 5% glutaraldehyde prepared in 0.1M sodium cacodylate buffer for 4 hours at room temperature. Fixed specimens were then washed in 0.1M cacodylate buffer three times, 15 min for each. The specimens were post-fixed in 1% buffered osmium tetroxide (OsO‫‬ ‫‬ ‫‬ ‫‬ ‫‬ ‫‬ 4) for 1-2 hours at 4°C. The tissue specimens were then washed twice in 0.1M cacodylate buffer three times, 15 min for each, then dehydrated in ascending grades of ethyl alcohol. The absolute alcohol was replaced by propylene oxide via a stepwise series of ethanol. Dehydrated specimens were embedded in an epoxy resin then were infiltrated at room temperature in a mixture of epoxy resin and propylene oxide at 60°C for 48 hours and then allowed to attain room temperature. Using a stereomicroscope, the mounted blocks were trimmed with razor blades to give a trapezoid-shaped face of less than 1 mm width and height as much as possible. The blocks were trimmed and sectioned at 1 µm thickness on Leica Ultracut UCT Ultramicrotome using a glass knife. Semi -thin sections were stained with toluidine blue and examined with the light microscope. The specimens were then re-trimmed to the selected region and ultrathin sections (60-90 nm thickness) were cut, on the same above ultramicrotome using a diamond knife, and picked up on copper grids.
The sections were double stained using uranyl acetate and lead citrate. After staining, the grids were washed in distilled water and then dried on filter paper. The stained sections were examined and photographed using a JEOL/1010 electron microscope at the "Electron Microscope Unit", in the Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Results and Discussion
Results
Examination of liver sections of the control animals showed the hepatocyte nucleus with circular smooth envelope and normal distribution of euchromatin. The cytoplasm contains the usual organelles of which rod-like or rounded mitochondria with intact cristae. Parallel cisternae of rough endoplasmic reticulum (rER), plenty amounts of glycogen and smooth endoplasmic reticulum (sER) were seen (Figure1).L-Carnitine group revealed an identical ultrastructural view similar to that demonstrated by the control group (Figure 2 ). Liver sections administrated methotrexate for 4 weeks revealed marked ultrastructural changes showing necrotic areas with eroded cell membranes. Nuclear lesions were observed as ill defined, electron translucent nuclei, with irregular outer membranes. Also pyknotic nuclei were prominent with shrunken and irregular outlines with abnormally electron dense chromatin. The hepatocyte cytoplasm contains shrunken, electron dense and malformed mitochondria. Rough endoplasmic reticulum with its associated ribosomes was essentially limited to scattered areas which showed fragmentation and severe damage. Dilated bile canaliculi and loss of hepatocyte microvilli were frequently observed. Also dilated, congested hepatic sinusoids, RBCʼs and collagen in the space of Disse were also prominent (Fig.3) . Sections of liver of animals treated with methotrexate and L-Carnitine for 4 weeks showed moderate improvement of the hepatocyte fine structure. Cell membranes and nuclear outlines of some hepatocytes restored the normal structural architecture. This was observed in most hepatocytes,while some others still showed malformation and irregularity.The majority of mitochondria appeared almost normal,with well-formed ultrastructural details and cristae mitochondrials,while others were still ill-defined and electron-dense. The rough endoplasmic reticulum appeared slightly dilated, and was slightly fragmented (Fig.4) .
The liver sections of animals treated with methotrexate for 4 weeks followed by L-Carnitine for other 4 weeks showed only mild improvement and involved a fraction of organelles, while the majority remained damaged or ill-defined as a result of methotrexate toxicity. Some nuclei appeared almost normal with regular smooth nuclear envelope and chromatin, while others lost their normal electron density and appeared degenerative. Perinuclear rough endoplasmic reticulum was partially restored, showing parallel profiles, while the smooth endoplasmic reticulum was dilated or fragmented. Some mitochondria regained their structural details, while the majority were abnormally electron-dense and malformed. Cytoplasmic matrix contained irregular vacuoles of various sizes indicating vacuolar degeneration (Fig.5 ) 
Discussion
Administration of Methotrexate to male albino rats with dose 0.045mg/100g b.w. twice per week for 4 weeks caused pathological alterations in the fine structure of the hepatocytes.
Electron microscopic examination of the liver ultrathin sections of rats given methotrexate showed a variety of mitochondrial abnormalities including pleomorphism, proliferation of mitochondria, swelling, and increase or decrease in the density of matrices. The present results were confirmed by Ali et al. (2005) who noticed proliferation of mitochondria that displayed a diversity in shape and size, as well as changes in the matrix and cristae. These changes, including the presence of flocculent wooly focal inclusions, were strongly suggestive of toxic injury resulting probably from a biochemically defective mitochondrial membranes since similar changes have been found in hepatocytes and other cells after administration of a variety of cytotoxic chemicals. Also, Hemmaid et al. (2015) reported that rats treated with a low therapeutic dose of methotrexate (10 mg/ kg bw) for 2, 4 and 6 weeks showed pleomorphic mitochondria characterized by increased density of matrices and without discrimination of their cristae. Giant mitochondria (gigantism) appeared in an elongated shaped. Other mitochondria suffered degenerated matrices cristae and lysis of cristae similar to paracrystalline inclusions bodies. Deteriorated mitochondria were surrounded with fragmented cisternae of the rough endoplasmic reticulum. Also, in rats treated with the high dose of Mtx for 6 weeks mitochondria has fragmented cristae as seemed to be filled with degenerated inclusions and small spherical vacuolated parts.
The accumulation of many altered mitochondria and the increased oxygen consumption following HD-MTX infusion may be either a compensatory reaction occurring at the organelle level or the result of the lesion's high demands upon the cell's energy resources (Ghadially, 1997).
Rubin (2001) postulated that severe degeneration of cell organelles especially the mitochondria and the rough endoplasmic reticulum, could be attributed to the oxygen metabolites with deficiency of the protective enzymes from the liver following drug treatments. Erdogan et al. (2015) suggested that Mtx increased MDA levels which confirmed the oxidative stress and explained the tissue damage.
Toxicity studies with methotrexate highlight the role of oxidative stress in causing toxicity on the liver, kidney, heart and other organs (Tousson et al.2014 ).
In the current work, pyknotic nucleus with homogeneous distribution of chromatin as well as irregular nuclear envelope, fragmented rough endoplasmic reticulum, increased lipid droplets and collagen fibres were common features of hepatocytes in response to Mtx treatment. In the same concern, Ali et al. In the present study, L-Carnitine treatment improved the ultrastructural abnormalities in liver cells related to MTX toxicity. It has been shown that L-carnitine was able to reduce liver damage in patients with nonalcoholic fatty liver disease (Chang et al., 2005) .
